FTC Statement on Appellate Court Decision Ordering Delisting of Teva Inhaler Patents
Date
Today, the U.S. Court of Appeals for the Federal Circuit affirmed a lower district court order against pharmaceutical maker Teva requiring the drugmaker to delist several asthma inhaler patents from...